These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25204194)

  • 41. ["Re-evaluation upon suspected event" is an approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations].
    Wu SX; Sun HF; Yang XH; Long HZ; Ye ZG; Ji SL; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2983-8. PubMed ID: 25423845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China.
    Huang R; Cai Y; Yang L; Shangguan X; Ghose B; Tang S
    Sci Rep; 2021 Apr; 11(1):8875. PubMed ID: 33893351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving reporting of adverse events and adverse drug reactions following injections of Chinese materia medica.
    Bian ZX; Tian HY; Gao L; Shang HC; Wu TX; Li YP; Zhang BL; Song L
    J Evid Based Med; 2010 Feb; 3(1):5-10. PubMed ID: 21349034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Safety of animal traditional Chinese medicine (TCM) injections].
    Yi Y; Li CY; Zhao Y; Zhang YS; Han JY; Wang LM; Jiang CH; Liang AH
    Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(22):4391-4396. PubMed ID: 30593229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Establish research model of post-marketing clinical safety evaluation for Chinese patent medicine].
    Zheng WK; Liu Z; Lei X; Tian R; Zheng R; Li N; Ren JT; Du XX; Shang HC
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(18):3693-6. PubMed ID: 26983223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of adverse reactions from contaminants in Chinese herbal medicines can be minimized by using quality products and qualified practitioners.
    Hohmann N; Koffler K
    Int J Environ Health Res; 2002 Mar; 12(1):99-100; author reply 101. PubMed ID: 11970820
    [No Abstract]   [Full Text] [Related]  

  • 47. [Research thoughts and technology system framework of jinfukang oral liquid secondary exploitation].
    Cheng XD; Feng L; Jia XB; Ding SM
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):941-5. PubMed ID: 25204195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Reduction of ADRs of essential traditional Chinese medicines].
    Nie Q; Liu Y; Chen J
    Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(2):340-344. PubMed ID: 28861983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Improvement and enhancement of traditional Chinese medicine injections].
    Li Y; Zhang J
    Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(14):1905-9. PubMed ID: 22016957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Explore and analyze influence factors of quality control on traditional Chinese medicine preparation].
    Liu Y; Feng L; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2017 May; 42(9):1808-1813. PubMed ID: 29082712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country.
    Dobos GJ; Tan L; Cohen MH; McIntyre M; Bauer R; Li X; Bensoussan A
    Complement Ther Med; 2005 Sep; 13(3):183-90. PubMed ID: 16150372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacovigilance idea should be introduced sufficiently into the safety monitoring and evaluation process of Chinese drugs].
    Zhang L; Yang XH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Sep; 29(9):843-6. PubMed ID: 19960988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of traditional Chinese medicine injection infusion with precise infusion apparatus].
    Han HM; Zhi YJ
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2758-9. PubMed ID: 23285928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of high-risk patients for ADR induced by traditional Chinese medicine injection: a nested case-control study.
    Jiang C; Shen J; Shou D; Wang N; Jing J; Zhang G; Gu J; Tian Y; Sun C; He J; Ma J; Wang X; Li G
    Sci Rep; 2019 Nov; 9(1):16721. PubMed ID: 31723184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical outcomes research of traditional Chinese medicine--introduce registry intensive hospital monitoring study protocol of traditiona Chinese medicine injection's safety].
    Yang W; Xie YM; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2683-5. PubMed ID: 23285907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis and exploration on adverse reactions of four kinds of andrographolide injections].
    Xiang D; Wang MD; Wang WQ; Shi CY; Xie XJ; Fang JG
    Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(12):2350-2355. PubMed ID: 28901084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A discussion of key issues on postmarketing reevaluation of Chinese medicine].
    Xie Y; Tian F
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1494-7. PubMed ID: 20822029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine - A Retrospective Analysis.
    Melchart D; Hager S; Dai J; Weidenhammer W
    Forsch Komplementmed; 2016; 23 Suppl 2():21-8. PubMed ID: 27272353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Retrospective Analysis on 1330 Adverse Event Reports of Qingkailing in China: Further Perception of Its Risks and Rational Use.
    Wu BL; He WX; Ke M; Shang-Guan XF; He GF; Huang R
    Curr Med Sci; 2018 Dec; 38(6):1103-1108. PubMed ID: 30536076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse drug reactions and adverse events of 33 varieties of traditional Chinese medicine injections on National Essential medicines List (2004 edition) of China: an overview on published literatures.
    Wang L; Yuan Q; Marshall G; Cui X; Cheng L; Li Y; Shang H; Zhang B; Li Y
    J Evid Based Med; 2010 May; 3(2):95-104. PubMed ID: 21349051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.